Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Total published articles

60 56 62 62 23 11 8 22 23 48 50 29

Research, Review articles and Editorials

38 44 28 40 2 7 7 14 10 24 27 18

Research communications, Review communications, Editorial communications, Case reports and Commentary

12 12 34 22 21 4 1 8 13 24 23 11

Conference proceedings

0 0 0 0 0 0 0 28 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

0 0 0 54 59 64 98 0 74 0 0 0
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2019 8
Important citations (462)

mcgill cm, brown tj, cheng yy, fisher ln, shanmugavelandy ss, gustafson sj, dunlap kl, lila ma, kester m, toran pt, claxton df. therapeutic effect of blueberry extracts for acute myeloid leukemia. international journal of biopharmaceutical sciences. 2018 jan;1(1).

tan sf, pearson jm, feith dj, loughran jr tp. the emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia. expert opinion on therapeutic targets. 2017 jun 3;21(6):583-90.

Gudjoncik a. marqueurs du métabolisme du fer et dérivés de la l-arginine dans la cardiopathie ischémique: mise en évidence, intérêt de leur évaluation et rôle du stress oxydant en phase aiguë d’infarctus du myocarde (doctoral dissertation, dijon).

Samba mondonga m. study of the role of the adaptor protein myd88 in the iron-sensing pathway and of the effect of curcumin in the development of anemia in a dss-induced colitis mouse model.

Wang jq, xu zh, liang wz, he jt, cui y, liu hy, xue lx, shi w, shao yk, mang j, xu zx. effects of c-jun n-terminal kinase on activin a/smads signaling in pc12 cell suffered from oxygen-glucose deprivation. cellular and molecular biology. 2016 feb 29;62(2):81-6.

Bai c, gao y, zhang x, yang w, guan w. melatonin promotes self-renewal of nestin-positive pancreatic stem cells through activation of the mt2/erk/smad/nestin axis. artificial cells, nanomedicine, and biotechnology. 2018 jan 2;46(1):62-74.

Hiçsönmez g. short-course high-dose methylprednisolone induces differentiation and apoptosis of myeloid leukemic cells. int j stem cell res ther. 2015;3:033.

hiçsönmez g. dear professor faris farassati, chief editor i would like to submit a commentary entitled ‘’short-course high-dose methylprednisolone induces differentiation and apoptosis of myeloid leukemic cells’’for the publication in international journal of stem cell research & therapy. since, patients with aml other than apl are still looking for the new hopes for their treatment, i would like to bring attention the potential use of short-course high-dose methylprednisolone as a differentiation and apoptosis ....

Mackiewicz-wysocka m, czerwiÃ?â??ska p, filas v, bogajewska e, kubicka a, przybyÃ?â??a a, dondajewska e, kolenda t, marszaÃ?â??ek a, mackiewicz a. oncogenic braf mutations and p16 expression in melanocytic nevi and melanoma in the polish population. advances in dermatology and allergology/postÃ?©py dermatologii i alergologii. 2017 oct;34(5):490.

Tran g, huynh tn, paller as. langerhans cell histiocytosis: a neoplastic disorder driven by ras-erk pathway mutations. journal of the american academy of dermatology. 2018 mar 1;78(3):579-90.

feldpausch e, sambidi s, cherukuri d, sidhu j. bcr/abl1-negative, triple-negative, myeloproliferative neoplasm with a hitherto undescribed, isolated, sh2b3 (lnk) gene mutation: a case report. human pathology: case reports. 2018 sep 1;13:4-8.

anuja k. uv rays leading to xeroderma pigmentosum. database.;31:40.

Charmsaz s, boyd aw. eph receptors as oncotargets. oncotarget. 2017 oct 10;8(47):81727.

Боднар ОВ, Скроцька ОИ, Жолобак Н. Влияние ионов церия (iv) на противовирусную активность интерферона І типа in vitro. ББК 28 Ф48.:50.

Жидецкий АВ, Шолух МВ, Ханнеман ЮР, Хандрик Р, Мотылевич ЖВ, Химанен ЮП. Оптимизация условий очистки и рефолдинга рекомбинантного эфрина-А5 из телец включения escherichia coli.

Жидецкий АВ. Рефолдинг рекомбинантного эктодомена эфринового рецептора типа А5.

an t, lisle j, zamora ap, slape c. abnormal genetic changes in hematopoietic stem cells of pre-leukemic mice.

Charmsaz s, scott am, boyd aw. targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against eph family receptors. experimental hematology. 2017 oct 1;54:31-9.

Charmsaz s, al-ejeh f, yeadon tm, miller kj, smith fm, stringer bw, moore as, lee ft, cooper lt, stylianou c, yarranton gt. epha3 as a target for antibody immunotherapy in acute lymphoblastic leukemia. leukemia. 2017 aug;31(8):1779.

Rahem rm, abuhmood aa, hussein l. association of t315i mutation with resistance to tyrosine kinase inhibitor therapy in patients with cml attended the oncology-hematology center in al-najaf city of iraq. karbala international journal of modern science. 2017 dec 1;3(4):231-40.

Top